Wegovy is approved by the FDA as a long-term medication, with no built-in stopping point. Most people who use it will need to continue indefinitely to maintain their weight loss. This isn’t a failure of willpower or a flaw in the drug’s design. It reflects how obesity works as a chronic condition, similar to how blood pressure medication manages hypertension rather than curing it.
The Titration Schedule: First 16 Weeks
You don’t start on the full dose. Wegovy follows a 16-week ramp-up schedule designed to reduce nausea and other digestive side effects:
- Weeks 1 through 4: 0.25 mg once weekly
- Weeks 5 through 8: 0.5 mg once weekly
- Weeks 9 through 12: 1 mg once weekly
- Weeks 13 through 16: 1.7 mg once weekly
- Week 17 onward: 2.4 mg once weekly (maintenance dose)
The first three dose levels exist only to get your body adjusted. They aren’t considered therapeutic doses for weight management. If side effects are rough at any step, your prescriber may hold you at that dose for an extra four weeks before moving up. Some adults stay at 1.7 mg as their maintenance dose if they can’t tolerate the full 2.4 mg.
When Weight Loss Peaks
In the major clinical trial (known as STEP 1), participants took semaglutide for 68 weeks, roughly 15 months. Weight loss continued gradually throughout that period, though the most dramatic changes happened in the first several months after reaching the maintenance dose. Most people see their weight stabilize somewhere between 12 and 18 months of treatment. After that, the goal shifts from losing weight to keeping it off, and that’s where the long-term nature of the medication becomes important.
What Happens When You Stop
This is the part most people searching this question really want to know. The evidence is clear and consistent: weight comes back after stopping.
A 2025 systematic review published in The BMJ analyzed data from thousands of participants across multiple trials. People who stopped taking newer medications like semaglutide and tirzepatide regained an average of 9.9 kilograms (about 22 pounds) within the first year after discontinuation. For the broader class of similar medications, the average regain was 6 kilograms (about 13 pounds) in that same timeframe. This isn’t a complete reversal of all progress, but it represents a substantial portion of what was lost.
The regain doesn’t happen overnight. It’s gradual, unfolding over months, which can make it easy to dismiss early on. But the trajectory is consistent enough across studies that researchers now describe it as “metabolic rebound” rather than simple relapse.
Why Weight Returns After Stopping
Wegovy works by mimicking a natural gut hormone called GLP-1. It suppresses appetite by acting on hunger signals in the brain, slows how quickly food leaves your stomach (so you feel full longer), and improves how your body handles blood sugar. All of these effects disappear when you stop taking it.
The rebound is layered. Some effects reverse quickly. Your stomach empties at its normal speed again within days or weeks, and the appetite-suppressing signals in your brain fade soon after. Other changes take longer to unwind. Hormonal shifts, particularly involving leptin (which helps regulate energy balance), reverse more gradually over weeks to months. The net result is that your appetite returns to where it was before treatment, and your body’s energy-conservation systems push you back toward your previous weight.
This is the same biological challenge that makes sustained weight loss difficult through diet and exercise alone. When you lose a significant amount of weight, your body reduces leptin levels and increases ghrelin (the hunger hormone), essentially turning up the volume on hunger signals. Wegovy overrides that response. Removing it lets it reassert itself.
Can You Ever Stop Taking It?
There’s no standard protocol for safely discontinuing Wegovy without regain. Some prescribers work with patients to find the lowest effective dose, which can reduce cost and side effects while still providing enough appetite suppression to maintain results. Others combine a lower dose with structured lifestyle changes to see if a reduced level of medication support is enough.
A small number of people who make significant, lasting changes to their eating patterns and activity levels during treatment may be able to maintain some of their weight loss after stopping. But the research so far suggests this is the exception, not the rule. The medication label itself describes the indication as maintaining weight reduction “long term,” and the FDA approved it with ongoing use in mind.
Cost and Access Over Time
The indefinite nature of treatment makes cost a real concern. Insurance coverage for Wegovy varies widely, and out-of-pocket prices remain high for many people. Interruptions in supply or coverage can force unplanned breaks in treatment, which the research suggests will lead to at least partial regain. If you’re considering starting Wegovy, it’s worth thinking about long-term affordability and insurance stability alongside the medical benefits. A medication that works brilliantly but that you can only afford for six months puts you in a difficult position given what the data shows about stopping.